发明名称 |
FORMULATION COMPRISING A GEMCITABINE-PRODRUG |
摘要 |
This invention relates to pharmaceutical formulations of gemcitabine-[phenyl-benzoxy-L-alaninyl)]-phosphate, a monophosphate derivative of the well-known oncology drug gemcitabine. In particular, the invention relates to formulations which comprise a polar aprotic solvent, preferably dimethyl acetamide (DMA). Formulations comprising these solvent provide therapeutically effective treatments of gemcitabine-[phenyl-benzoxy-L-alaninyl)]-phosphate. The invention also relates to methods of using said formulations and kits comprising said formulations. |
申请公布号 |
US2017095498(A1) |
申请公布日期 |
2017.04.06 |
申请号 |
US201515308475 |
申请日期 |
2015.06.25 |
申请人 |
NuCana Biomed Limited |
发明人 |
Griffith Hugh;Kennovin Gordon |
分类号 |
A61K31/7068;A61K47/26;A61K47/18;A61K47/44;A61K9/00;A61K9/08 |
主分类号 |
A61K31/7068 |
代理机构 |
|
代理人 |
|
主权项 |
1. A pharmaceutical formulation comprising:
gemcitabine[phenyl-benzoxy-L-alaninyl)]-phosphate; a polar aprotic solvent; and optionally one or more pharmaceutically acceptable excipients. |
地址 |
Edinburgh GB |